These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 13469592)

  • 21. Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.
    Romeike BF; Hellwig D; Heimann A; Kempski O; Feiden W; Kirsch CM; Samnick S
    Anticancer Res; 2004; 24(6):3971-6. PubMed ID: 15736441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Native chemical ligation at phenylalanine.
    Crich D; Banerjee A
    J Am Chem Soc; 2007 Aug; 129(33):10064-5. PubMed ID: 17658806
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of N-benzoyl-d-phenylalanine on lipid profile in liver of neonatal streptozotocin diabetic rats.
    Pari L; Ashokkumar N
    Fundam Clin Pharmacol; 2005 Oct; 19(5):563-8. PubMed ID: 16176335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Total substitution of phenylalanine by o- or m-fluorophenylalanine in proteins of Escherichia coli].
    MUNIER RL
    C R Hebd Seances Acad Sci; 1959 Mar; 248(12):1870-3. PubMed ID: 13639380
    [No Abstract]   [Full Text] [Related]  

  • 25. A new route to fullerene substituted phenylalanine derivatives.
    Yang J; Barron AR
    Chem Commun (Camb); 2004 Dec; (24):2884-5. PubMed ID: 15599455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships of Leu-Enkephalin analog with (4-Carboxamido)phenylalanine substituted for tyrosine: a molecular dynamics study.
    Wang YC; Wu YC; Yeh CC; Hwang CC
    Biopolymers; 2007 Jun; 86(3):231-9. PubMed ID: 17377963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new method for asperphenamate synthesis and its antimicrobial activity evaluation.
    Pomini AM; Ferreira DT; Braz-Filho R; Saridakis HO; Schmitz W; Ishikawa NK; Faccione M
    Nat Prod Res; 2006 May; 20(6):537-41. PubMed ID: 16835084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric conjugate reductions with samarium diiodide: asymmetric synthesis of (2S,3R)- and (2S,3S)-[2-2H,3-2H]-leucine-(S)-phenylalanine dipeptides and (2S,3R)-[2-(2)H,3-2H]-phenylalanine methyl ester.
    Davies SG; Rodriguez-Solla H; Tamayo JA; Cowley AR; Concellon C; Garner AC; Parkes AL; Smith AD
    Org Biomol Chem; 2005 Apr; 3(8):1435-47. PubMed ID: 15827639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing structure in the polymorphic domain of the L-enantiomer of N-benzoyl-phenylalanine by means of 2D solid-state NMR spectroscopy and DFT calculations.
    Hughes CE; Olejniczak S; Helinski J; Ciesielski W; Repisky M; Andronesi OC; Potrzebowski MJ; Baldus M
    J Phys Chem B; 2005 Dec; 109(49):23175-82. PubMed ID: 16375280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of D-amino-acid amidase complexed with L-phenylalanine and with L-phenylalanine amide: insight into the D-stereospecificity of D-amino-acid amidase from Ochrobactrum anthropi SV3.
    Okazaki S; Suzuki A; Mizushima T; Komeda H; Asano Y; Yamane T
    Acta Crystallogr D Biol Crystallogr; 2008 Mar; 64(Pt 3):331-4. PubMed ID: 18323628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for the recognition of para-benzoyl-L-phenylalanine by evolved aminoacyl-tRNA synthetases.
    Liu W; Alfonta L; Mack AV; Schultz PG
    Angew Chem Int Ed Engl; 2007; 46(32):6073-5. PubMed ID: 17628477
    [No Abstract]   [Full Text] [Related]  

  • 32. Neighbouring group processes in the deamination of protonated phenylalanine derivatives.
    Lioe H; O'Hair RA
    Org Biomol Chem; 2005 Oct; 3(20):3618-28. PubMed ID: 16211098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octreotide therapy for nateglinide-induced hypoglycemia.
    Sherk DK; Bryant SM
    Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of the nateglinide polymorphism structure and the drug effect.
    Li G; Chen JY; Lü GL; Xu QW
    Yao Xue Xue Bao; 2005 Oct; 40(10):958-60. PubMed ID: 16408818
    [No Abstract]   [Full Text] [Related]  

  • 35. A Highly stereospecific and efficient synthesis of homopentafluoro- phenylalanine.
    Babu IR; Hamill EK; Kumar K
    J Org Chem; 2004 Aug; 69(16):5468-70. PubMed ID: 15287798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-inhibiting action of 1,6-di-(2-bromoethyl-amino)-1,6-dideoxy-D-mannitol dihydrobromide [(DBM (R13)].
    BALO J; KENDREY G; JUHASZ J; BESZNYAK I
    Br J Cancer; 1959 Dec; 13(4):634-41. PubMed ID: 13848916
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental results with sarcolysine.
    LARIONOV LF
    Acta Unio Int Contra Cancrum; 1957; 13(3):393-400. PubMed ID: 13469592
    [No Abstract]   [Full Text] [Related]  

  • 38. Some results of the clinical use of sarcolysine (dl-p-dl/2-chlorethyl/aminophenil-alanin-chlorhydrate).
    PEREVODCHIKOVA NI
    Acta Unio Int Contra Cancrum; 1957; 13(3):457-61. PubMed ID: 13469604
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the effects of sarcolysine on the Yoshida sarcoma and sarcoma 180].
    YAMAGUCHI H; KURAHORI T; YOSHIMURA Y
    Gan; 1956 Dec; 47(3-4):366-8. PubMed ID: 13415042
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new chemotherapeutic agent for control of malignant tumors: p-di-(-2-chloroethyl)-aminophenylanine (sarcolysine)].
    SELIGER H
    Krebsarzt; 1956 Dec; 11(6):342-3. PubMed ID: 13399137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.